Background
==========

Nasopharyngeal carcinoma (NPC) is a malignant tumor that occurs in the nasopharyngeal mucosa epithelium \[[@b1-medscimonit-24-6151],[@b2-medscimonit-24-6151]\] and is generally treated with radiation therapy \[[@b3-medscimonit-24-6151],[@b4-medscimonit-24-6151]\]. However, the complications and adverse reactions after radiotherapy and chemotherapy cannot be ignored \[[@b5-medscimonit-24-6151]\], such as oral mucosal lesions, mouth-opening difficulties, xerostomia, hearing loss, and nasal congestion \[[@b6-medscimonit-24-6151],[@b7-medscimonit-24-6151]\], but most patients with NPC only receive conventional discharge health education after their radiotherapy and chemotherapy treatment in the hospital. Because of their poor self-management ability, it not only affects the treatment effect, but also seriously affects their quality of life.

A smartphone medical application (app) can play a positive role in the self-management of patients and improve the compliance behavior of patients. In 2011, a survey in the United States showed that 84% of respondents have a smartphone, and that 53% of people with smartphones already use apps in clinical practice. The use of smartphones and apps is prevalent among orthopedic care providers in academic centers \[[@b8-medscimonit-24-6151]\]. Another survey revealed patient behavior patterns that would be useful in future app development. Being able to record, analyze, seamlessly share, and obtain feedback on the SMBG data using an iPhone/iTouch app might benefit patients \[[@b9-medscimonit-24-6151]\]. GM Turnermcgrievy reported the potential benefits of mobile monitoring methods during behavioral weight loss trials. Future studies should examine ways to predict which self-monitoring method works best for an individual to increase adherence \[[@b10-medscimonit-24-6151]\]. However, the current research on the use of mobile medical apps for discharged NPC patients who underwent concurrent radiotherapy and chemotherapy has not been further studied. Therefore, in the present study we used a smartphone medical app as an intervention method for discharged NPC patients who underwent radiotherapy and chemotherapy to share information about NPC disease, such as observation and treatment of complications of radiotherapy and chemotherapy, as well as regular re-examination, to improve the self-management ability of discharged patients so that they can effectively deal with complications of radiotherapy and chemotherapy and improve their quality of life.

Material and Methods
====================

Patients
--------

We randomly divided 132 patients admitted to the Rhinology Department of our hospital from March 2015 to March 2017 into 2 groups: 65 patients were assigned to the intervention group and 67 patients were assigned to the control group. Inclusion criteria were: (1) patients with NPC confirmed by histopathology and received radiotherapy and chemotherapy for the first time, (2) had the ability to take care of themselves, (3) had reading ability, (4) provided informed consent. Exclusion criteria were: (1) severe cardiovascular and cerebrovascular complications, (2) severe cognitive, mental, and language disorders. All patients provided signed informed consent. This research was approved by the Institutional Ethics Committee of First Affiliated Hospital of Zhengzhou University.

Intervention method
-------------------

Control group: Patients in the control group received a conventional follow-up visit after hospital discharge, in which patients were informed after discharge about relevant issues by their physician, including diet, exercise, and rehabilitation exercise, and were told that they should attend re-examinations at 3 and 6 months after discharge.

In the intervention group, when patients were discharged, they were asked to download the smartphone medical app and complete rehabilitation after discharge according to the app guidelines. The smartphone medical app intervention manager asked patients about their use of the app by telephone follow-up every month. According to characteristics of NPC, the app includes 3 special modules: a re-examination reminder, a knowledge base, and an online expert. With the re-examination reminder, 3 days before the re-examination, the app administrator notifies the patients to review. The knowledge base informs patients consists of text, pictures, and videos, including a rehabilitation exercise video, assessment and treatment of adverse reactions and complications, medication, diet, activities and rest, and psychological guidances. With the online expert, every Wednesday and Saturday, a doctor is scheduled to answer patients' questions online to help doctors know about recovery after discharge. Patients can also interact with other patients, share information about rehabilitation after discharge, and upload rehabilitation pictures.

Data collection and processing
------------------------------

We collected and evaluated data on complications after radiotherapy and chemotherapy, rehabilitation exercise compliance, and quality of life at discharge and at 3 months and 6 months after discharge. Patients were asked to complete a questionnaire and report on their condition according to uniform instructions, and this process was completed by the patients themselves. Patients were contacted by telephone to remind them about follow-up at 3 and 6 months, and at the same time complete the patient condition form. Patients who could not go to the hospital for re-examination were followed-up by mail or telephone.

Statistical analysis
--------------------

SPSS17.0 software was used for statistical analysis. Enumeration data were checked by chi-square test, and the independent-samples *t* test was used to assess the data. Rank data were tested by rank sum test method, and the level of test was 0.05 (α=0.05).

Results
=======

Basic information
-----------------

We divided the 132 patients with NPC who received radiotherapy and chemotherapy for the first time, in accordance with the random number table method, into a control group (67 patients) and an intervention group (65 patients) ([Table 1](#t1-medscimonit-24-6151){ref-type="table"}). There was no significant difference between the 2 groups in gender, age, course of disease, or chemotherapy and radiotherapy regimens (P\>0.05).

Comparison of radiotherapy and chemotherapy complications
---------------------------------------------------------

[Table 2](#t2-medscimonit-24-6151){ref-type="table"} compares complications in the 2 groups, including xerostomia, oral mucositis, hearing loss, mouth-opening difficulties, and nasal congestion. Patients had varying degrees of xerostomia, oral mucositis, hearing loss, mouth-opening difficulties, and nasal congestion at discharge. There was no significant difference in the incidence of these complications between the 2 groups (P\>0.05). Xerostomia was the most common complication, and the incidence rates in the 2 groups were 89% and 92%, respectively.

At 6 months after discharge, the incidence and severity of oral mucositis, mouth-opening difficulties, xerostomia, and nasal obstruction in the intervention group was significantly lower than that in the control group, and there was a significant difference between the 2 groups (P\<0.05). This indicated that the intervention had positive effects on improving xerostomia and oral mucositis for discharged patients. The app knowledge base includes measures to improve the incidence of these complications, such as encouraging patients to rinse with dilute saline and use sodium bicarbonate mouthwash, keep the mouth clean, increase intake of liquids, jointly present nasal irrigation content in the form of pictures and videos, and help patients improve cognitive level and compliance, so as to improve the symptoms of nasal congestion.

Comparison of compliance of rehabilitation exercise between 3 and 6 months after discharge
------------------------------------------------------------------------------------------

Taking mouth-opening exercises and nasal irrigation compliance as examples, the results of rehabilitation training compliance are shown in [Table 3](#t3-medscimonit-24-6151){ref-type="table"}. Results showed that the compliance of mouth-opening exercises and nasal irrigation in the intervention group was higher than that in the control group at 3 and 6 months after discharge (P\<0.05). The incidence of mouth-opening difficulties and nasal congestion was significantly lower than in control group at 6 months after discharge, indicating that the smartphone app can effectively improve the symptoms of mouth-opening difficulties and nasal congestion.

Comparison of quality of life between the 2 groups at 6 months after discharge
------------------------------------------------------------------------------

Quality of life in the 2 groups after discharge was investigated using the Quality of Life Questionnaire (QLQ-C30) \[[@b11-medscimonit-24-6151]\], which was designed by the European Cancer Treatment Research Organization (EORTC; [Table 4](#t4-medscimonit-24-6151){ref-type="table"}**)**. At 6 months after discharge, quality of life scores of control and intervention groups were better than at discharge, indicating that most patients had improved quality of life. In the functional and overall quality of life field, scores of the intervention group were higher than in the control group at 6 months after discharge (P\<0.05). In the area of symptoms, scores of fatigue and pain in the intervention group were lower than those in the control group (P\<0.05). In the single area, such as sleep loss, appetite loss, and constipation, the scores of the intervention group was lower than that of the control group (P\<0.05). The results indicated that the app can further improve fatigue, pain, sleep loss, appetite loss, constipation, and other symptoms, which is helpful to further improve the overall quality of life of patients.

Discussion
==========

With the progress of society and the change of medical mode, evaluation of the effect of cancer treatment focuses more on improvement of quality of life after treatment \[[@b12-medscimonit-24-6151]\]. After receiving radiotherapy and chemotherapy, patients with NPC have varying degrees of complications and adverse reactions, physical damage, and reduction of social function, which puts patients under great pressure, and quality of life can be seriously affected.

Patients and their families lack understanding of the disease system and pay great attention to treatment in the hospital, but they despise the rehabilitation exercise treatment and follow-up visit after the operation and discharge \[[@b13-medscimonit-24-6151]\]. Studies have shown that the quality of life of cancer patients is related to their optimistic attitudes towards life \[[@b14-medscimonit-24-6151]\]. Use of an app can enhance the communication between doctors and patients, and it can be fast and convenient for doctors to provide health information to patients and develop some appropriate measures and methods to relieve nervousness and anxiety of patients as well as help them actively carry out functional exercises \[[@b15-medscimonit-24-6151],[@b16-medscimonit-24-6151]\]. Moreover, the app allows physicians to keep abreast of the patient's condition and quickly provide comprehensive and systematic treatment, care, and rehabilitation and carry out a timely follow-up \[[@b17-medscimonit-24-6151]\].

Patients may suffer from mouth-opening difficulties, nasal congestion, and other symptoms after their discharge, among which mouth-opening difficulties are the more severe complication \[[@b18-medscimonit-24-6151]\], the incidence of which first decreased and then increased. At 1--2 months after discharge, the incidence of mouth-opening difficulties was the highest, and then gradually decreased as oral mucosa injuries healed. At about 6 months after discharge, mouth-opening difficulties occurred again. It is an effective method to prevent and reduce the incidence and severity of mouth-opening difficulties by early opening mouth exercises and keeping on doing the exercise \[[@b19-medscimonit-24-6151]--[@b21-medscimonit-24-6151]\]. In the app, there are mouth-opening exercises videos, and it is necessary to encourage patients to follow the video every day and do it; patients should adhere to exercise even if early oral mucositis and xerostomia occur after radiotherapy. Due to the sustained rehabilitation exercise of the intervention group, the incidence and severity of mouth-opening difficulties were lower than in control group (P\<0.05).

In addition, nasal lavage can alleviate nasal mucosa swelling, dryness, nasal congestion, and other adverse reactions. There are pictures and videos co-presented about nasal irrigation and other operations in the app, so that patients can easily understand and master the correct methods. The pictures and videos can be watched repeatedly, which can improve cognitive level and compliance.

Nasal irrigation can reduce the nasal swelling, dryness, nasal obstruction, and other adverse reactions of NPC patients after radiotherapy. It can also promote normal mucosal repair and reduce the incidence of complications \[[@b22-medscimonit-24-6151]\]. After the patient is discharged, it is necessary to improve the compliances using nasal lavage. All these activities can be performed with the help of the relevant videos to improve patient compliance. Consistent and correct performance of exercises can effectively improve patient symptoms.

In addition, patient quality of was life improved significantly in the intervention group. The reason may be that discharged patients in the intervention group gained the help of health education, psychological intervention and medical staff guidance from the app, which fully mobilized the patient's own potential to play its initiative to enhance its confidence and ability to solve health problems, so as to effectively carry out self-management and regulation and promote physical and mental healths and improve the quality of life.

Conclusions
===========

This study shows that rational use of a smartphone app can improve exercise compliance of patients with NPC after radiotherapy and chemotherapy, reduce adverse reactions and complications due to radiotherapy and chemotherapy, and improve quality of life and satisfaction after discharge.
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###### 

Demographic and health characteristics of the participants.

  --------------------------------------------------------------------------------------------------------------------------------------------
  Items                                   Classification               Intervention group (N1=65)\   Control group (N2=67)\   t/χ^2^   P
                                                                       χ㈄±n (%)                     χ㈄±n (%)                         
  --------------------------------------- ---------------------------- ----------------------------- ------------------------ -------- -------
  Gender                                  Male                         39 (60.0)                     44 (65.7)                0.009    0.924

  Female                                  26 (40.0)                    23 (34.3)                                                       

  Age (Yr)                                                             44.32±11.03                   42.28±10.37              0.883    0.463

  Course of disease                       IV stage                     11 (16.9)                     13 (19.4)                1.067    0.587

  III stage                               28 (43.1)                    29 (43.3)                                                       

  II stage and below                      26 (40.0)                    25 (37.3)                                                       

  Chemotherapy regimen                    Single chemotherapy          45 (69.2)                     49 (73.1)                0.135    0.714

  Combination chemotherapy                20 (30.8)                    18 (26.9)                                                       

  Radiotherapy regimen                    Conventional radiotheraphy   18 (27.7)                     16 (23.9)                0.025    0.875

  Intensity modulated radiation therapy   47 (72.3)                    51 (76.1)                                                       
  --------------------------------------------------------------------------------------------------------------------------------------------

###### 

Comparison of side effects and complications of radiotherapy and chemotherapy in two groups \[N (%)\].

  Items                        Grade     At discharge   6 months after discharge                                                  
  ---------------------------- --------- -------------- -------------------------- --------- ------- --------- --------- -------- -------
  Oral mucositis               0         8 (12)         13 (19)                    −0.757    0.449   34 (52)   52 (78)   −2.138   0.033
  I\~II                        40 (61)   40 (59)        29 (45)                    12 (19)                                        
  III\~IV                      17 (27)   14 (22)        2 (3)                      3 (3)                                          
  Mouth opening difficulties   0         16 (24)        15 (22)                    0.000     1.000   23 (36)   45 (68)   −2.397   0.017
  I\~II                        38 (58)   42 (63)        31 (48)                    14 (22)                                        
  III\~IV                      11 (18)   10 (15)        11 (16)                    8 (10)                                         
  Xerostomia                   0\~I      39 (60)        43 (64)                    −0.503    0.615   42 (65)   51 (76)   −2.335   0.020
  II\~III                      26 (40)   24 (36)        23 (35)                    16 (24)                                        
  Hearing loss                 Without   20 (31)        19 (29)                    0.010     0.919   22 (34)   24 (36)   0.545    0.460
  Exist                        45 (69)   46 (71)        43 (66)                    43 (64)                                        
  Nasal congestion             0         12 (18)        17 (25)                    1.220     0.223   25 (39)   37 (56)   −2.084   0.037
  I\~II                        29 (45)   35 (53)        25 (39)                    25 (38)                                        
  II\~III                      24 (37)   15 (22)        15 (22)                    5 (6)                                          

Group C is control group, and Group I is intervention group.

###### 

Comparison of rehabilitation exercise compliance between two groups of patients after discharge \[N (%)\].

  Items                                  3 months after discharge   6 months after discharge                                                          
  -------------------------------------- -------------------------- -------------------------- --------- --------- ------- -------- --------- ------- -------
  Compliance of mouth opening exercise   Full compliance            8 (12)                     20 (19)   6.610     0.037   5 (12)   8 (19)    7.369   0.013
  Partial compliance                     40 (61)                    36 (59)                    23 (6)    33 (59)                                      
  Non-compliance                         17 (27)                    11 (22)                    37 (2)    26 (22)                                      
  Compliance of nasal irrigation         Full compliance            12 (12)                    24 (19)   3.685     0.048   8 (12)   16 (19)   8.356   0.015
  Partial compliance                     20 (61)                    16 (59)                    34 (61)   19 (59)                                      
  Non-compliance                         33 (27)                    27 (22)                    23 (27)   32 (22)                                      

Group C is control group, and Group I is intervention group.

###### 

QLQ-C30 questionnaire of two groups at discharge and 6 months after discharge.

  Field                                         At discharge   6 months after discharge                                                               
  ------------------------------- ------------- -------------- -------------------------- ------- ------------- ------------- ------------- --------- ---------
  Functional field                PF            59.62±12.18    58.79±10.58                0.293   0.771         80.22±11.35   91.36±8.63    4.444     \<0.001
  RF                              55.86±16.53   56.33±14.69    0.121                      0.904   63.54±14.23   72.18±10.13   2.812         0.007     
  EF                              53.29±12.36   54.18±12.68    0.287                      0.775   62.53±11.34   73.62±10.21   4.139         \<0.001   
  CF                              73.22±13.25   74.37±14.76    0.331                      0.742   77.63±12.31   83.14±10.64   1.928         0.049     
  SF                              57.89±17.46   56.37±16.35    0.362                      0.719   70.54±15.14   76.91±12.19   1.572         0.121     
  Symptom field                   FA            52.09±16.49    53.82±18.32                0.400   0.690         38.64±13.32   22.14±12.54   5.139     \<0.001
  NV                              20.98±12.69   21.56±11.02    0.196                      0.845   2.54±5.61     2.13±4.96     0.311         0.756     
  PA                              55.46±20.41   57.21±21.35    0.338                      0.737   8.24±11.75    3.12±8.36     2.018         0.048     
  DY                              10.21±14.56   12.84±13.24    0.761                      0.449   2.34±9.63     2.11±8.54     0.102         0.919     
  SL                              61.02±22.12   59.74±21.36    0.237                      0.813   13.14±20.11   6.13±16.58    1.531         0.131     
  AP                              73.82±23.12   71.21±21.58    0.481                      0.632   9.62±10.54    3.28±8.56     2.657         0.009     
  CO                              15.34±16.57   16.40±15.80    0.264                      0.792   8.11±12.33    3.82±9.22     1.585         0.118     
  DI                              5.39±10.50    6.10±9.44      0.286                      0.776   5.10±8.51     5.86±8.47     0.361         0.719     
  FI                              43.85±34.17   41.28±35.11    1.867                      0.067   39.66±30.12   38.22±31.01   0.190         0.850     
  Overall quality of life field   QL            34.15±10.31    32.14±9.65                 0.811   0.420         62.15±11.17   72.03±9.07    3.908     \<0.001

Group C is control group, and Group I is intervention group. PF -- physical functionong; RF -- role functioning; EF -- emotional functioning; CF -- cognitive functioning; SF -- social functioning; FA -- fatigue; NV -- nausea and vomiting; PA -- pain; DY -- dyspnoea; SL -- sleep loss; AP -- appetite loss; CO -- constipation; DI -- diarrhoea; FI -- financial difficulties; QL --: quality of life.
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